An inexpensive repurposed drug called fluvoxamine can save the lives of COVID-19 patients and cut hospital admissions by up to 30 per cent, says a study co-led by McMaster University. McMaster researcher…


The fluvoxamine arm of the TOGETHER trial, a randomised adaptive platform trial investigating the efficacy of repurposed treatments for COVID-19 among high-risk Brazilian adult outpatients, is the largest trial of the SSRI fluvoxamine…


Researchers are developing a deep learning network capable of detecting disease biomarkers with a much higher degree of accuracy. Experts at the University of Waterloo’s Cheriton School of Computer Science have created…


There are many types of cancer treatments. But which ones work best varies from patient to patient. Currently, doctors determine which treatment to try for a patient based on where in their…


In the past few years, artificial intelligence models of language have become very good at certain tasks. Most notably, they excel at predicting the next word in a string of text; this…
/penicillin-56a26f733df78cf77275aedb.jpg)
/penicillin-56a26f733df78cf77275aedb.jpg)
The mechanism which allows β-lactam antibiotics, including penicillin, to kill MRSA has been revealed for the first time. An international team of researchers led by the University of Sheffield discovered that β-lactam…


The sharpest images ever of living bacteria have been recorded by UCL researchers, revealing the complex architecture of the protective layer that surrounds many bacteria and makes them harder to be killed…
In a study published in the American Journal of Kidney Diseases (AJKD), researchers found that two-fold higher levels of neutrophil gelatinase-associated lipocalin, monocyte chemoattractant protein, and kidney injurymolecule-1 were associated with increased…


Although antidepressants are one of the most frequently taken medications in the United States (11% of the population takes antidepressants) 60% of depressed patients do not benefit from their first antidepressant. The…

